Literature DB >> 26001537

Preoperative localization of adult nesidioblastosis using ⁶⁸Ga-DOTA-exendin-4-PET/CT.

Emanuel Christ1, Damian Wild2, Kwadwo Antwi2, Beatrice Waser3, Melpomeni Fani2, Stefanie Schwanda4, Tobias Heye2, Christoph Schmid5, Hans Ulrich Baer6, Aurel Perren3, Jean Claude Reubi7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26001537     DOI： 10.1007/s12020-015-0633-7

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  3 in total

1.  Persistent hyperinsulinemic hypoglycemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence, and characterization of beta-cell changes.

Authors:  Martin Anlauf; Daniel Wieben; Aurel Perren; Bence Sipos; Paul Komminoth; Andreas Raffel; Marie L Kruse; Christian Fottner; Wolfram T Knoefel; Heiner Mönig; Philipp U Heitz; Günter Klöppel
Journal:  Am J Surg Pathol       Date:  2005-04       Impact factor: 6.394

2.  GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting.

Authors:  Meike Körner; Martin Stöckli; Beatrice Waser; Jean Claude Reubi
Journal:  J Nucl Med       Date:  2007-05       Impact factor: 10.057

3.  Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study.

Authors:  Emanuel Christ; Damian Wild; Susanne Ederer; Martin Béhé; Guillaume Nicolas; Martyn E Caplin; Michael Brändle; Thomas Clerici; Stefan Fischli; Christoph Stettler; Peter J Ell; Jochen Seufert; Beat Gloor; Aurel Perren; Jean Claude Reubi; Flavio Forrer
Journal:  Lancet Diabetes Endocrinol       Date:  2013-07-25       Impact factor: 32.069
  3 in total
  15 in total

Review 1.  Molecular imaging in neuroendocrine tumors: recent advances, controversies, unresolved issues, and roles in management.

Authors:  Tetsuhide Ito; Robert T Jensen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-02       Impact factor: 3.243

2.  Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study.

Authors:  Kwadwo Antwi; Melpomeni Fani; Tobias Heye; Guillaume Nicolas; Christof Rottenburger; Felix Kaul; Elmar Merkle; Christoph J Zech; Daniel Boll; Deborah R Vogt; Beat Gloor; Emanuel Christ; Damian Wild
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-07-28       Impact factor: 9.236

3.  Fully automated GMP production of [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 for clinical use.

Authors:  Irina Velikyan; Ulrika Rosenstrom; Olof Eriksson
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-07-15

4.  Spontaneous hypoglycemia: diagnostic evaluation and management.

Authors:  Leelavathy Kandaswamy; Rajeev Raghavan; Joseph M Pappachan
Journal:  Endocrine       Date:  2016-03-07       Impact factor: 3.633

5.  Glucagon-Like Peptide-1 Receptor PET/CT with 68Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study.

Authors:  Yaping Luo; Qingqing Pan; Shaobo Yao; Miao Yu; Wenming Wu; Huadan Xue; Dale O Kiesewetter; Zhaohui Zhu; Fang Li; Yupei Zhao; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2016-01-21       Impact factor: 10.057

6.  Hyperinsulinaemic, hypoglycaemic syndrome due to acquired nesidioblastosis in a cat.

Authors:  Lydia E Hambrook; Amanda A Ciavarella; Judith S Nimmo; Julie Wayne
Journal:  JFMS Open Rep       Date:  2016-07-07

Review 7.  Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms.

Authors:  Melpomeni Fani; Petra Kolenc Peitl; Irina Velikyan
Journal:  Pharmaceuticals (Basel)       Date:  2017-03-15

8.  Molecular Imaging to the Surgeons Rescue: Gallium-68 DOTA-Exendin-4 Positron Emission Tomography-Computed Tomography in Pre-operative Localization of Insulinomas.

Authors:  U N Pallavi; Vindhya Malasani; Ishita Sen; Parul Thakral; Sugandha Dureja; Vineet Pant; Vinay Samuel Gaikwad; Arvind Sabharwal
Journal:  Indian J Nucl Med       Date:  2019 Jan-Mar

9.  Diagnostic challenges in a patient with an occult insulinoma:68 Ga-DOTA-exendin-4 PET/CT and 68Ga-DOTATATE PET/CT.

Authors:  Elisa Bongetti; Melissa H Lee; David A Pattison; Rodney J Hicks; Richard Norris; Nirupa Sachithanandan; Richard J MacIsaac
Journal:  Clin Case Rep       Date:  2018-03-01

10.  Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4.

Authors:  Simon A M Kaeppeli; Roger Schibli; Thomas L Mindt; Martin Behe
Journal:  EJNMMI Radiopharm Chem       Date:  2019-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.